Literature DB >> 19536400

Acute coronary thrombosis in a patient with diabetes and severe hyperglycemia.

Jason D Roberts1, Gavin Y Oudit, David H Fitchett.   

Abstract

The pathophysiological processes responsible for acute coronary events in diabetic patients, in addition to the conventional factors associated with plaque rupture, include an enhanced prothrombotic state. This enhanced prothrombotic state results from multiple abnormalities of the coagulation system including platelet activation, impaired fibrinolysis and increased activity of the coagulation cascade. Studies have also demonstrated that severe hyperglycemia can result in an exacerbation of the underlying pro-thrombotic state, indicating that patients with extreme hyperglycemia are subject to an even greater thrombotic risk. The present case illustrates the thrombotic hazards associated with severe hyperglycemia.

Entities:  

Mesh:

Year:  2009        PMID: 19536400      PMCID: PMC2722502          DOI: 10.1016/s0828-282x(09)70113-8

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  5 in total

1.  Hyperglycemia stimulates coagulation, whereas hyperinsulinemia impairs fibrinolysis in healthy humans.

Authors:  Michiel E Stegenga; Saskia N van der Crabben; Marcel Levi; Alex F de Vos; Michael W Tanck; Hans P Sauerwein; Tom van der Poll
Journal:  Diabetes       Date:  2006-06       Impact factor: 9.461

Review 2.  Diabetes mellitus: a hypercoagulable state.

Authors:  M E Carr
Journal:  J Diabetes Complications       Date:  2001 Jan-Feb       Impact factor: 2.852

Review 3.  Abnormalities of coagulation, platelet function, and fibrinolysis associated with syndromes of insulin resistance.

Authors:  David J Schneider
Journal:  Coron Artery Dis       Date:  2005-12       Impact factor: 1.439

4.  Effects of increased concentrations of glucose on platelet reactivity in healthy subjects and in patients with and without diabetes mellitus.

Authors:  Friederike K Keating; Burton E Sobel; David J Schneider
Journal:  Am J Cardiol       Date:  2003-12-01       Impact factor: 2.778

Review 5.  Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes.

Authors:  Giuseppina Basta; Ann Marie Schmidt; Raffaele De Caterina
Journal:  Cardiovasc Res       Date:  2004-09-01       Impact factor: 10.787

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.